Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
中國石油化工股份
00386
5
上海石油化工股份
00338
澳洲市場個股詳情
Invex Therapeutics Ltd (IXC)
- 0.125
- 0.0000.00%
延時20分鐘行情交易中 05/15 12:49 (悉尼)
939.42萬總市值-20.83市盈率(靜)
0.125最高價0.125最低價4.86萬股成交量0.125今開0.125昨收6076.00成交額0.18052周最高0.11%換手率7515.38萬總股本0.07552周最低-0.011每股收益TTM570.97萬流通值0.522歷史最高虧損市盈率(靜)4567.72萬流通股0.038歷史最低-0.006每股收益(静)0.00%振幅--股息TTM2.05市淨率1股每手--股息率TTM
Invex Therapeutics Ltd (IXC) 損益表
季報+年報
顯示同比
| (FY)2025/06/30 | (FY)2024/06/30 | (FY)2023/06/30 | (FY)2022/06/30 | (FY)2021/06/30 | (FY)2020/06/30 | |
|---|---|---|---|---|---|---|
| 營業總收入 | ||||||
| 主營業務成本 | ||||||
| 毛利 | ||||||
| 營業費用 | -71.59%95.12萬 | -62.71%334.8萬 | 111.69%897.93萬 | 73.65%424.17萬 | -28.33%244.27萬 | 340.8萬 |
| 銷售和管理費用 | -54.01%49.19萬 | -43.06%106.96萬 | 8.86%187.85萬 | 24.28%172.57萬 | -2.12%138.85萬 | --141.85萬 |
| -管理費用 | -54.01%49.19萬 | -43.06%106.96萬 | 8.86%187.85萬 | 24.28%172.57萬 | -2.12%138.85萬 | --141.85萬 |
| 研發費用 | -88.82%20.45萬 | -73.14%182.88萬 | 218.54%680.82萬 | 187.23%213.73萬 | -42.77%74.41萬 | --130.02萬 |
| 其他營業費用 | -43.32%25.48萬 | 53.67%44.95萬 | -22.75%29.25萬 | 22.13%37.87萬 | -55.01%31.01萬 | --68.93萬 |
| 營業利潤 | 71.59%-95.12萬 | 62.71%-334.8萬 | -111.69%-897.93萬 | -73.65%-424.17萬 | 28.33%-244.27萬 | -340.8萬 |
| 營業外利息收入與支出淨額 | -52.74%23.24萬 | -38.30%49.18萬 | 897.84%79.71萬 | -49.69%7.99萬 | -4.17%15.88萬 | 16.57萬 |
| 營業外利息收入 | -52.74%23.24萬 | -38.30%49.18萬 | 897.84%79.71萬 | -49.69%7.99萬 | -4.17%15.88萬 | --16.57萬 |
| 其他淨收入/費用 | -80.08%24.19萬 | 180.87%121.43萬 | 107.20%43.23萬 | 20.87萬 | -11.79萬 | |
| 特殊收入（費用） | ---- | ---- | ---- | ---- | ---- | ---11.79萬 |
| -減：資本性資產減值 | ---- | ---- | ---- | ---- | ---- | --11.79萬 |
| 其他營業外收入（費用） | -80.08%24.19萬 | 180.87%121.43萬 | 107.20%43.23萬 | --20.87萬 | ---- | ---- |
| 稅前利潤 | 70.95%-47.69萬 | 78.81%-164.18萬 | -96.04%-774.99萬 | -73.09%-395.31萬 | 32.03%-228.39萬 | -336.03萬 |
| 所得稅 | 0 | 0 | 0 | 0 | 0 | 0 |
| 除稅後的權益收益 | ||||||
| 除稅後利潤 | 70.95%-47.69萬 | 78.81%-164.18萬 | -96.04%-774.99萬 | -73.09%-395.31萬 | 32.03%-228.39萬 | -336.03萬 |
| 持續經營利潤 | 70.95%-47.69萬 | 78.81%-164.18萬 | -96.04%-774.99萬 | -73.09%-395.31萬 | 32.03%-228.39萬 | ---336.03萬 |
| 歸屬於少數股東的淨利潤 | ||||||
| 歸屬於母公司的淨利潤 | 70.95%-47.69萬 | 78.81%-164.18萬 | -96.04%-774.99萬 | -73.09%-395.31萬 | 32.03%-228.39萬 | -336.03萬 |
| 優先股派息 | ||||||
| 其他優先股派息 | ||||||
| 歸屬於普通股股東的淨利潤 | 70.95%-47.69萬 | 78.81%-164.18萬 | -96.04%-774.99萬 | -73.09%-395.31萬 | 32.03%-228.39萬 | -336.03萬 |
| 基本每股收益 | 71.10%-0.0063 | 78.86%-0.0218 | -96.01%-0.1031 | -73.03%-0.0526 | 49.16%-0.0304 | -0.0598 |
| 稀釋每股收益 | 71.10%-0.0063 | 78.86%-0.0218 | -96.01%-0.1031 | -73.03%-0.0526 | 49.16%-0.0304 | -0.0598 |
| 每股派息 | 0 | 0.1863 | ||||
| 會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
